Vical Incorporated Stock Price and Value Analysis

Should you buy Vical Incorporated stock? (NasdaqCM:VICL). Let's see how it does in our automated value investing analysis system.

VICL Free Cash Flow Trend

Free Cash Flow trendline for VICL
Free Cash Flow trendline for Vical Incorporated

Hmm, we can't give any reliable projection for Vical Incorporated's growth rate. The company either has too few years of historical data for us to examine, or it's in the habit of losing money.

None of this means it's a bad stock. Maybe it's new and growing quickly, or maybe it's turning things around. We can't say anything sensible about it, so we won't say it's obviously undervalued right now. Proceed at your own risk!

  • This company is solid.
  • This stock looks overpriced.
  • This company is not making money.
  • This company has wild ups and downs.
  • This company pays no dividend.

Inside the VICL Numbers

VICL Price
(Vical Incorporated stock price per share)
[?] PE Ratio versus Sector 439% higher than other Healthcare stocks
[?] PE Ratio versus Industry 89% higher than other Biotechnology stocks
[?] Cash Yield -30.10%
[?] Free Cash Flow Jitter 41%

Is Vical Incorporated Stock on Sale?

Based on our analysis, we believe that you should not buy Vical Incorporated right now. It might be a good stock to own—we just can't prove it with value analysis right now. Proceed with caution.

Should You Buy VICL Stock?

Does Vical Incorporated have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.